Company: DMAC
Filing Date: 2025-05-13
Form Type: 10-Q
Source: 0001437749-25-016488
Chunk: 3

Company: DiaMedica Therapeutics Inc.
Filing Date: 2025-05-13
Form: 10-Q
Item: Part II, Item 1
Chunk 3
---
. The NCC indicated that a ruling would be issued on or about June 20, 2025.

From time to time, we may be subject to other various ongoing or threatened legal actions and proceedings, including those that arise in the ordinary course of business, which may include employment matters and breach of contract disputes. Such matters are subject to many uncertainties and to outcomes that are not predictable with assurance and that may not be known for extended periods of time. Other than the PRA Netherlands matter noted above, we are not currently engaged in or aware of any threatened legal actions.

ITEM 1A. RISK FACTORS